Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Sao Paulo
04:03:00 2026-08-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 7.180 BRL | +2.72% |
|
+1.84% | -21.36% |
| Market Cap | 880M 168M 145M 137M 124M 233M 16.09B 237M 1.6B 626M 8.06B 632M 618M 26.77B | P/E 2024 |
6.95x | P/E 2025 | 9.42x |
|---|---|---|---|---|---|
| Enterprise Value | 2.05B 391M 338M 318M 289M 543M 37.41B 552M 3.72B 1.45B 18.73B 1.47B 1.44B 62.25B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.2x |
| Free-Float |
32.86% | Yield 2024 |
8.86% | Yield 2025 | - |
| 1 day | +2.72% | ||
| 1 week | +1.84% | ||
| Current month | +3.76% | ||
| 1 month | +4.66% | ||
| 3 months | +6.37% | ||
| 6 months | -15.53% | ||
| Current year | -21.36% |
| 1 week | 6.66 | 7.19 | |
| 1 month | 6.11 | 7.21 | |
| Current year | 6.11 | 9.7 | |
| 1 year | 6.11 | 9.7 | |
| 3 years | 3.4 | 9.7 | |
| 5 years | 2.92 | 9.7 | |
| 10 years | 2.87 | 11.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 57 | 2010-04-20 |
| Director of Finance/CFO | 68 | 1992-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CHM | Chairman | 57 | 2008-04-02 |
| Director/Board Member | 91 | 2010-04-20 | |
| Director/Board Member | 62 | 2010-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/8/25 | Others | 1 | 0.0000% | |||
| 12/9/24 | Sell | 12,200 | 0.0099% | |||
| 12/9/24 | Sell | 12,400 | 0.0100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.72% | +1.84% | -7.35% | +78.61% | 168M | ||
| +1.44% | -0.07% | +28.97% | +98.40% | 101B | ||
| +1.70% | -0.52% | +56.55% | +152.90% | 54.69B | ||
| 0.00% | 0.00% | +4.20% | +270.19% | 24.3B | ||
| -1.13% | -0.66% | -12.22% | -14.48% | 8.24B | ||
| +0.54% | +2.52% | -30.54% | -26.20% | 7.73B | ||
| -0.24% | -1.53% | -13.83% | -21.78% | 6.64B | ||
| +1.24% | +2.26% | +9.25% | +19.91% | 6.33B | ||
| +0.31% | -1.34% | -6.08% | +19.44% | 4.98B | ||
| -0.59% | +1.40% | -4.71% | -5.89% | 3.74B | ||
| Average | +0.60% | -0.35% | +2.42% | +57.11% | 21.81B | |
| Weighted average by Cap. | +1.10% | -0.32% | +26.18% | +112.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.15B 1.94B 1.68B 1.57B 1.43B 2.69B 186B 2.74B 18.45B 7.21B 92.92B 7.29B 7.13B 309B | 11.45B 2.19B 1.89B 1.78B 1.62B 3.04B 209B 3.09B 20.81B 8.14B 105B 8.22B 8.04B 348B |
| Net income | 115M 21.9M 18.91M 17.77M 16.16M 30.39M 2.09B 30.89M 208M 81.42M 1.05B 82.21M 80.43M 3.48B | 119M 22.72M 19.63M 18.44M 16.77M 31.53M 2.17B 32.05M 216M 84.49M 1.09B 85.31M 83.46M 3.62B |
| Net Debt | 1.02B 194M 168M 158M 143M 270M 18.59B 274M 1.85B 723M 9.31B 730M 714M 30.93B | 1.17B 223M 193M 181M 165M 309M 21.32B 315M 2.12B 829M 10.68B 837M 819M 35.48B |
Employees
7,077
Sector
Pharmaceuticals
Calendar
Oct. 27
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | R$7.180 | +0.14% | 197,500 |
| 26-08-13 | R$7.170 | +2.58% | 103,700 |
| 26-08-12 | R$6.990 | -0.14% | 105,300 |
| 26-08-11 | R$7.000 | -0.14% | 218,100 |
| 26-08-10 | R$7.010 | -0.57% | 131,100 |
- Stock Market
- Stocks
- PFRM3 Stock
Select your edition
All financial news and data tailored to specific country editions
















